aTyr Pharma ATYR Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -105.3%-25.8pp | -107.8%-28.1pp | -103.2%-25.3pp | -85.2%-23.5pp | -79.5%-24.0pp | |
| Return on assets | -79.2%-18.9pp | -78.1%-19.2pp | -75.8%-16.9pp | -64.2%-15.7pp | -60.3%-17.1pp | |
| Return on invested capital | -105.9%-27.2pp | -109.2%-22.6pp | -101.5%-22.6pp | -87.5%-24.9pp | -78.6%-18.9pp | |
| Liquidity | ||||||
| Current ratio | 5.8×-2.0× | 5.3×-0.2× | 5.9×+0.5× | 5.6×-2.0× | 7.8×+1.7× | |
| Quick ratio | 5.8×-2.0× | 5.3×-0.2× | 5.9×+0.5× | 5.6×-2.0× | 7.8×+1.7× | |
| Cash ratio | 0.9×-0.1× | 0.7×0.0× | 0.4×-0.4× | 1.1×+0.5× | 1×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×-0.1× | 0.2×0.0× | 0.2×0.0× | |
| Debt-to-assets | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $0.59-31.9% | $0.73-23.0% | $0.83-4.2% | $0.83-26.4% | $0.87-32.1% | |
| Valuation | ||||||
| Market capitalization | $54.88M-88.2% | —— | —— | —— | —— | |
| Enterprise value | $57.17M— | —— | —— | —— | —— | |
| Price / book | 0.9×— | —— | —— | —— | —— | |
| Free cash flow yield | -108.1%— | —— | —— | —— | —— | |
| Earnings yield | -127.6%— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do aTyr Pharma's ratios come from?
- Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
